IDEX Biometrics ASA Statistics
Total Valuation
IDXAF has a market cap or net worth of 13.98 million. The enterprise value is 15.09 million.
| Market Cap | 13.98M |
| Enterprise Value | 15.09M |
Important Dates
The next estimated earnings date is Friday, August 15, 2025.
| Earnings Date | Aug 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 3.83B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +108.89% |
| Shares Change (QoQ) | +57.37% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.77B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.40 |
| PB Ratio | 97.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.15 |
| EV / Sales | 25.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.13 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 14.77.
| Current Ratio | 1.65 |
| Quick Ratio | 0.43 |
| Debt / Equity | 14.77 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.16 |
| Interest Coverage | -9.27 |
Financial Efficiency
Return on equity (ROE) is -412.24% and return on invested capital (ROIC) is -168.26%.
| Return on Equity (ROE) | -412.24% |
| Return on Assets (ROA) | -89.89% |
| Return on Invested Capital (ROIC) | -168.26% |
| Return on Capital Employed (ROCE) | -459.16% |
| Revenue Per Employee | 21,222 |
| Profits Per Employee | -487,889 |
| Employee Count | 30 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0.26 |
Taxes
| Income Tax | -118,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +900.00% in the last 52 weeks. The beta is 2.06, so IDXAF's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | +900.00% |
| 50-Day Moving Average | 0.60 |
| 200-Day Moving Average | 1.37 |
| Relative Strength Index (RSI) | 32.29 |
| Average Volume (20 Days) | 4,950 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDXAF had revenue of 573,000 and -13.17 million in losses. Loss per share was -2.38.
| Revenue | 573,000 |
| Gross Profit | -960,000 |
| Operating Income | -19.06M |
| Pretax Income | -13.29M |
| Net Income | -13.17M |
| EBITDA | -18.21M |
| EBIT | -19.06M |
| Loss Per Share | -2.38 |
Balance Sheet
The company has 1.06 million in cash and 2.13 million in debt, giving a net cash position of -1.07 million.
| Cash & Cash Equivalents | 1.06M |
| Total Debt | 2.13M |
| Net Cash | -1.07M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 144,000 |
| Book Value Per Share | 0.02 |
| Working Capital | 3.23M |
Cash Flow
In the last 12 months, operating cash flow was -13.38 million and capital expenditures 15,000, giving a free cash flow of -13.37 million.
| Operating Cash Flow | -13.38M |
| Capital Expenditures | 15,000 |
| Free Cash Flow | -13.37M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -167.54% |
| Operating Margin | -3,325.48% |
| Pretax Margin | -2,319.55% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IDXAF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -108.89% |
| Shareholder Yield | n/a |
| Earnings Yield | -94.22% |
| FCF Yield | -95.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 9, 2024. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jan 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
IDXAF has an Altman Z-Score of -58.19 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -58.19 |
| Piotroski F-Score | 1 |